Large gap with delayed quotes
Analysis date: 31.10.2025
Global Evaluation
Positive
Positive
The stock is classified in the positive zone since 24.10.2025.
Interest
Strong
Strong
Three stars since 24.10.2025.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 10.10.2025 at a price of 2.92.
Evaluation
Strongly undervalued
Strongly undervalued
Based on its growth potential and our own criteria, we believe the share price is currently undervalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 24.10.2025.
4wk Rel Perf
1.68%
1.68%
The four-week dividend-adjusted overperformance versus STOXX600 is 1.68%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 29.08.2025.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.04%.
Mkt Cap in $bn
3.58
3.58
With a market capitalization between $2 & $8bn, VIVENDI SE is considered a mid-cap stock.
G/PE Ratio
1.34
1.34
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
25.71
25.71
The estimated PE is for the year 2027.
LT Growth
33.17%
33.17%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
8
8
Over the last seven weeks, an average of 8 analysts provided earnings per share estimates.
Dividend Yield
1.28%
1.28%
The twelve month estimated dividend yield represents 32.94% of earnings forecasts.
Beta
108
108
For 1% of index variation, the stock varies on average by 1.08%.
Correlation
0.48
0.48
48.01% of stock movements are explained by index variations.
Value at Risk
0.37
0.37
The value at risk is estimated at EUR 0.37. The risk is therefore 12.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.01.2002
02.01.2002